Rubedo Life Sciences Announces European Expansion Ahead of First Clinical Trial Health and Family Rubedo Life Sciences Announces European Expansion Ahead of First Clinical Trial AETOSWire October 24, 2024 Phase 1 dermatology study of lead candidate RLS-1496 to initiate in early 2025 in Europe European headquarters... Read More Read more about Rubedo Life Sciences Announces European Expansion Ahead of First Clinical Trial
